BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 27894074)

  • 1. LSD1 mediates MYCN control of epithelial-mesenchymal transition through silencing of metastatic suppressor NDRG1 gene.
    Ambrosio S; Amente S; Saccà CD; Capasso M; Calogero RA; Lania L; Majello B
    Oncotarget; 2017 Jan; 8(3):3854-3869. PubMed ID: 27894074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lysine-specific demethylase (LSD1/KDM1A) and MYCN cooperatively repress tumor suppressor genes in neuroblastoma.
    Amente S; Milazzo G; Sorrentino MC; Ambrosio S; Di Palo G; Lania L; Perini G; Majello B
    Oncotarget; 2015 Jun; 6(16):14572-83. PubMed ID: 26062444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low NDRG1 mRNA expression predicts a poor prognosis in neuroblastoma patients.
    Matsushita K; Uchida K; Saigusa S; Ide S; Hashimoto K; Koike Y; Otake K; Inoue M; Tanaka K; Kusunoki M
    Pediatr Surg Int; 2013 Apr; 29(4):363-8. PubMed ID: 23296375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-15a-5p, miR-15b-5p, and miR-16-5p inhibit tumor progression by directly targeting MYCN in neuroblastoma.
    Chava S; Reynolds CP; Pathania AS; Gorantla S; Poluektova LY; Coulter DW; Gupta SC; Pandey MK; Challagundla KB
    Mol Oncol; 2020 Jan; 14(1):180-196. PubMed ID: 31637848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and evaluation of small molecule inhibitors of LSD1 for use against MYCN-expressing neuroblastoma.
    Mills CM; Turner J; Piña IC; Garrabrant KA; Geerts D; Bachmann AS; Peterson YK; Woster PM
    Eur J Med Chem; 2022 Dec; 244():114818. PubMed ID: 36223680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The growth-inhibitory Ndrg1 gene is a Myc negative target in human neuroblastomas and other cell types with overexpressed N- or c-myc.
    Li J; Kretzner L
    Mol Cell Biochem; 2003 Aug; 250(1-2):91-105. PubMed ID: 12962147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Druggable epigenetic suppression of interferon-induced chemokine expression linked to
    Seier JA; Reinhardt J; Saraf K; Ng SS; Layer JP; Corvino D; Althoff K; Giordano FA; Schramm A; Fischer M; Hölzel M
    J Immunother Cancer; 2021 May; 9(5):. PubMed ID: 34016720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CTCF cooperates with noncoding RNA MYCNOS to promote neuroblastoma progression through facilitating MYCN expression.
    Zhao X; Li D; Pu J; Mei H; Yang D; Xiang X; Qu H; Huang K; Zheng L; Tong Q
    Oncogene; 2016 Jul; 35(27):3565-76. PubMed ID: 26549029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of a MYCN-interacting isoform of the tumor suppressor BIN1 is reduced in neuroblastomas with unfavorable biological features.
    Tajiri T; Liu X; Thompson PM; Tanaka S; Suita S; Zhao H; Maris JM; Prendergast GC; Hogarty MD
    Clin Cancer Res; 2003 Aug; 9(9):3345-55. PubMed ID: 12960121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TdIF1-LSD1 Axis Regulates Epithelial-Mesenchymal Transition and Metastasis via Histone Demethylation of E-Cadherin Promoter in Lung Cancer.
    Liu Q; Xiong J; Xu D; Hao N; Zhang Y; Sang Y; Wang Z; Zheng X; Min J; Diao H; Raphael J; Maleki Vareki S; Koropatnick J; Min W
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LSD1-mediated epigenetic modification contributes to ovarian cancer cell migration and invasion.
    Li Y; Wan X; Wei Y; Liu X; Lai W; Zhang L; Jin J; Wu C; Shao Q; Shao G; Lin Q
    Oncol Rep; 2016 Jun; 35(6):3586-92. PubMed ID: 27109588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MYCN amplified neuroblastoma requires the mRNA translation regulator eEF2 kinase to adapt to nutrient deprivation.
    Delaidelli A; Negri GL; Jan A; Jansonius B; El-Naggar A; Lim JKM; Khan D; Oo HZ; Carnie CJ; Remke M; Maris JM; Leprivier G; Sorensen PH
    Cell Death Differ; 2017 Sep; 24(9):1564-1576. PubMed ID: 28574509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-myc downstream regulated gene 1 (NDRG1) promotes metastasis of human scirrhous gastric cancer cells through epithelial mesenchymal transition.
    Ureshino H; Murakami Y; Watari K; Izumi H; Kawahara A; Kage M; Arao T; Nishio K; Yanagihara K; Kinoshita H; Kuwano M; Ono M
    PLoS One; 2012; 7(7):e41312. PubMed ID: 22844455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic regulation of epithelial to mesenchymal transition by the Lysine-specific demethylase LSD1/KDM1A.
    Ambrosio S; Saccà CD; Majello B
    Biochim Biophys Acta Gene Regul Mech; 2017 Sep; 1860(9):905-910. PubMed ID: 28720390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA AC142119.1 facilitates the progression of neuroblastoma by epigenetically initiating the transcription of MYCN.
    Yang R; Liu N; Li T; Liu F; Zhang J; Zhao H; Zou L; He X
    J Transl Med; 2023 Sep; 21(1):659. PubMed ID: 37741985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel Thiosemicarbazones Inhibit Lysine-Rich Carcinoembryonic Antigen-Related Cell Adhesion Molecule 1 (CEACAM1) Coisolated (LYRIC) and the LYRIC-Induced Epithelial-Mesenchymal Transition via Upregulation of N-Myc Downstream-Regulated Gene 1 (NDRG1).
    Xi R; Pun IH; Menezes SV; Fouani L; Kalinowski DS; Huang ML; Zhang X; Richardson DR; Kovacevic Z
    Mol Pharmacol; 2017 May; 91(5):499-517. PubMed ID: 28275050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FOXD3 is a novel tumor suppressor that affects growth, invasion, metastasis and angiogenesis of neuroblastoma.
    Li D; Mei H; Qi M; Yang D; Zhao X; Xiang X; Pu J; Huang K; Zheng L; Tong Q
    Oncotarget; 2013 Nov; 4(11):2021-44. PubMed ID: 24269992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MOF Acetylates the Histone Demethylase LSD1 to Suppress Epithelial-to-Mesenchymal Transition.
    Luo H; Shenoy AK; Li X; Jin Y; Jin L; Cai Q; Tang M; Liu Y; Chen H; Reisman D; Wu L; Seto E; Qiu Y; Dou Y; Casero RA; Lu J
    Cell Rep; 2016 Jun; 15(12):2665-78. PubMed ID: 27292636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LSD1 activation promotes inducible EMT programs and modulates the tumour microenvironment in breast cancer.
    Boulding T; McCuaig RD; Tan A; Hardy K; Wu F; Dunn J; Kalimutho M; Sutton CR; Forwood JK; Bert AG; Goodall GJ; Malik L; Yip D; Dahlstrom JE; Zafar A; Khanna KK; Rao S
    Sci Rep; 2018 Jan; 8(1):73. PubMed ID: 29311580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of LSD1 by Pargyline inhibited process of EMT and delayed progression of prostate cancer in vivo.
    Wang M; Liu X; Guo J; Weng X; Jiang G; Wang Z; He L
    Biochem Biophys Res Commun; 2015 Nov; 467(2):310-5. PubMed ID: 26435505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.